Lyme Diagnostics Ltd. is focused on the more exact, routine diagnostics of Lyme disease, building on the innovative technologies developed primarily by Dr. Bózsik, one of the first-generation Lyme scientists. We offer the results of 35 years of work by 9 medical professionals. Currently, our novel diagnostic methods are supplemented with laboratory-standard, widely-accepted diagnostic procedures. Having successfully passed the widest ever clinical testing in Europe – we are now offering our screening method across Europe, and soon in North America.
Blog
Informative articles about Lyme disease
ABOUT US
Alleviate the suffering of patients
for GP's
Diagnosing Lyme borreliosis
DualDur reagent and method was developed based on 30 years of experience in examining spirochetes, and diagnosing Lyme disease. It is not dependent on the immune reaction of the body, which may be absent, especially in the early stages of the disease. It doesn’t search for the genetic material of the bacteria.
It is pure morphology: it will show spirochetes from 4 ml of blood. We will see only the spirochetes, 1,000x concentrated, alive and moving. Confirmed by specific staining and 40,000 tests, it also passed the largest-base clinical trial in Europe.
for clinics & labs
A new test for your portfolio
- Reproducibility
- 93% sensitivity
- 89% specificity
- Clinically proven 96% Positive Predictive Value*
Why not add this new test, DualDur, to you portfolio: screening for Lyme borreliosis?
*PPV indicates the likelihood that a test can successfully identify that a specific person does have a target condition, that is Lyme borreliosis.
for clinics & labs
A new test for your portfolio
- Reproducibility
- 93% sensitivity
- 89% specificity
Why not add this new test, DualDur, to you portfolio: screening for Lyme borreliosis? It is based on a completely new concept. Coming soon!